Search

2 result(s) for 'author#"Junquan Zeng"' within BMC

1. Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway

   Side population (SP) cells, which have similar features to those of cancer stem cells, show resistance to dexamethasone (Dex) treatment. Thus, new drugs that can be used in combination with Dex to reduce the p...

   Authors: Wenfeng He, Yonghui Fu, Yongliang Zheng, Xiaoping Wang, Bin Liu and Junquan Zeng

   Citation: BMC Cancer 2021 21:125

   Content type: Research article

   Published on: 6 February 2021

   • View Full Text
   • View PDF

2. Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression

   HBV promotes cell survival by upregulating the expression of the cellular inhibitor of apoptosis protein 2 (cIAP2), however whether it is involved in HBV-induced sorafenib resistance in liver cancer remains un...

   Authors: Shouhua Zhang, Nuoya Li, Yanling Sheng, Wen Chen, Qiangliang Ma, Xin Yu, Jianping Lian, Junquan Zeng, Yipeng Yang and Jinlong Yan

   Citation: Infectious Agents and Cancer 2021 16:20

   Content type: Research Article

   Published on: 23 March 2021

   • View Full Text
   • View PDF